The Clinical Research Core will provide a platform and infrastructure in which CRC investigators develop, implement, execute, monitor, and analyze CRC clinical trials and collect clinical information for patients enrolled in the CRC tissue bank. An Intranet-based Clinical Informatics Management System (CIMS) was developed to database clinical and laboratory information and monitor patients enrolled in the CRC tissue bank and treated on CRC multi-center clinical trials via an intranet in real-time.The CRC Clinical Research Core will have the following objectives: 1. Stimulate clinical trial development linked with correlative studies. Design, data collection and analyses of new protocols developed by CRC investigators will be fully supported. 2. Develop predictive models and identify and confirm prognostic factors for clinical endpoints including time to treatment, response to treatment, time to progression, and survival. 3. Develop systems for data exchange between different databases in order to increase access to available clinical data. 4. Further develop CIMS and patient database to assure complete, accurate clinical and laboratory data. 5. Provide a clinical trial-specific structure to utilize CIMS for CRC clinical trials. 6. Provide a platform in which CRC investigators performing laboratory studies interface with Biostatistics Core to request clinical information for analyses. 7. Coordinate CRC ClinicalAdvisory Committee activities. 8. Maintain complete regualtory documentation including IRB correspondence, SAE reports, FDA correspondence and audit results for all CRC clinical sites.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA081534-11
Application #
8068817
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2010-05-01
Budget End
2011-04-30
Support Year
11
Fiscal Year
2010
Total Cost
$1,015,416
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Barr, Paul M; Robak, Tadeusz; Owen, Carolyn et al. (2018) Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2. Haematologica 103:1502-1510
Kondo, K; Shaim, H; Thompson, P A et al. (2018) Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway. Leukemia 32:960-970
Hasan, Md Kamrul; Yu, Jian; Widhopf 2nd, George F et al. (2018) Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia. Blood 132:170-178
Ten Hacken, Elisa; Valentin, Rebecca; Regis, Fara Faye D et al. (2018) Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies. JCI Insight 3:
Gribben, John G (2018) How and when I do allogeneic transplant in CLL. Blood 132:31-39
Sivina, Mariela; Werner, Lillian; Rassenti, Laura et al. (2018) Dynamic changes in CCL3 and CCL4 plasma concentrations in patients with chronic lymphocytic leukaemia managed with observation. Br J Haematol 180:597-600
Ott, Christopher J; Federation, Alexander J; Schwartz, Logan S et al. (2018) Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia. Cancer Cell 34:982-995.e7
Balatti, Veronica; Tomasello, Luisa; Rassenti, Laura Z et al. (2018) miR-125a and miR-34a expression predicts Richter syndrome in chronic lymphocytic leukemia patients. Blood 132:2179-2182
Vangapandu, Hima V; Chen, Huiqin; Wierda, William G et al. (2018) Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cells. Leuk Lymphoma 59:1427-1438
Yu, Jian; Chen, Yun; Chen, Liguang et al. (2018) Cirmtuzumab inhibits ibrutinib-resistant, Wnt5a-induced Rac1 activation and proliferation in mantle cell lymphoma. Oncotarget 9:24731-24736

Showing the most recent 10 out of 562 publications